Skip to content

OM Pharma Pediatric Wheezing Screening

This is a 9-month Phase 2, randomized, double-blind, placebo-controlled,
multicenter study to assess the efficacy and safety of daily treatment with OM-85 compared to placebo, when given on top of standard of care treatment, in reducing wheezing events (WEs) during the 6-month Treatment period in children aged 6 months to 5 years with previous recurrent WEs.
1.Please enter your name for us to contact you.
2.Please enter a phone number for us to contact you.
3.Is your child aged six months to five years old?
4.How frequently does your child use an inhaler or a medication such as montelukast or zafirlukast?
5.How many times did your child have a wheezing or asthma event in the last 12 months?
6.Is your child up to date on their vaccinations according to the CDC's guidelines?
7.Does your child have any known physical respiratory tract abnormalities?
8.Is your child's wheezing known to be caused by gastroesophageal reflux?
9.Does your child have any other known chronic respiratory diseases?
10.Does your child have an autoimmune disease or deficiency?
11.Does your child have any other major medical issues?
12.Was your child born prematurely, before 34 weeks?
13.Does your child have cancer, or any other malignancy?
14.Is your child taking any steroids such as prednisolone?
15.Has your child taken immunosuppressants, immunostimulants, or gamma
globulins within the last 6 months?
16.Has your child had a major surgery in the last three months?